Greenwich LifeSciences Switched Drug Product Mid-Pivotal Trial. The FDA Has Rules About That.
Greenwich LifeSciences announced mid-trial use of commercially manufactured GP2 in its Phase III FLAMINGO-01 study. What looks like a...
GLSI-100
Greenwich LifeSciences announced mid-trial use of commercially manufactured GP2 in its Phase III FLAMINGO-01 study. What looks like a...